Maryland Matters
Danielle J. Brown
November 17, 2025
EXCERPT:
“The Maryland Prescription Drug Affordability Board took steps towards finally approving caps on what the state would pay for the first two prescription drugs, Jardiance and Farxiga. The price caps have been years in the making, and may not be finalized for months.
“It’s a major step forward in making high-cost drugs more affordable for state and local governments,” said Vinny DeMarco, a longtime supporter of the board’s effort and president of the Maryland Health Care for All Coalition. “It’s very important that this happens as soon as possible to start the clock ticking on when they can make high-cost drugs more affordable for everybody.”
PDAB staff estimates that setting an upper payment limit based on the maximum fair price for Farxiga would save state and local governments an estimated $4.9 million. That estimate does not reflect any rebates or discounts that the state receives for Farxiga, so true savings are not yet clear.
For Jardiance, staff estimates savings could reach $8 million if the state sets an upper payment limit based on maximum fair price. That number, also, does not consider rebates or discounts that the state receives.”
Read the full article at: https://marylandmatters.org/2025/11/17/maryland-board-moves-to-set-ceiling-on-what-state-will-pay-for-jardiance-farxiga/
Last modified: November 24, 2025
